Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.8%

4 terminated out of 51 trials

Success Rate

87.9%

+1.4% vs benchmark

Late-Stage Pipeline

16%

8 trials in Phase 3/4

Results Transparency

28%

8 of 29 completed with results

Key Signals

8 with results88% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (6)
P 1 (6)
P 2 (3)
P 3 (3)
P 4 (5)

Trial Status

Completed29
Unknown6
Recruiting5
Not Yet Recruiting4
Terminated4
Active Not Recruiting2

Trial Success Rate

87.9%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (51)

Showing 20 of 20 trials
NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

NCT07532850Not Yet RecruitingPrimary

Study on the Pharmacokinetic Characteristics of Liposomal Amphotericin B in Patients With Invasive Fungal Infections Undergoing Plasma Exchange Therapy

NCT06983665Not ApplicableActive Not RecruitingPrimary

Human Bioequivalence Study of Liposomal Amphotericin B for Injection

NCT05611892Completed

Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

NCT06977490Not ApplicableCompletedPrimary

Human Bioequivalence Study of Amphotericin B Liposome for Injection

NCT04240886Phase 2TerminatedPrimary

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

NCT06105411RecruitingPrimary

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions

NCT07120581Active Not RecruitingPrimary

Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections

NCT06433128UnknownPrimary

Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

NCT04157465Not ApplicableCompleted

Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients

NCT06640296Enrolling By InvitationPrimary

L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis

NCT06537726Recruiting

Breath Analysis for the Detection of Invasive Fungal Infections

NCT05534529Phase 1TerminatedPrimary

Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age

NCT06754436Phase 4Not Yet RecruitingPrimary

Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO)

NCT00634049Phase 3Completed

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

NCT04619147CompletedPrimary

Invasive Fungal Infections in Patients Following Stem Cell Transplant

NCT05688592RecruitingPrimary

Usefulness of PET-CT for Invasive Fungal Infection

NCT03174457CompletedPrimary

Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study

NCT06498310RecruitingPrimary

Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

NCT05491733Phase 1CompletedPrimary

A Bioequivalence Study of APX001 High-load and Low-load Tablets

Scroll to load more

Research Network

Activity Timeline